Quick Takeaways: Why It Matters? Loyal’s completion of the RXE efficacy requirement for LOY‑003 means all three of its canine longevity candidates (LOY‑001, LOY‑002, LOY‑003) have now met the FDA’s efficacy bar under the Expanded Conditional Approval pathway, putting the compan...
Cover Story Featured Article Product Launch Product Showcase Nestlé Invests CHF 157M to Expand Purina Pet Food Production Nestlé is investing more than CHF 157 million to expand its Purina pet food manufacturing site in Rayong, Thailand, increasing production capacity for pet food and trea...
Dechra Launches Domidine Equine Sedative in the US Quick Takeaways: Why It Matters? Dechra’s US launch of Domidine (detomidine) adds a generic, cost‑effective alpha‑2 agonist to the equine sedation market, giving veterina...
Quick Takeaways: Why It Matters? Petwealth’s partnership with Kennel Connection aims to embed molecular (PCR) health screening directly into boarding, daycare, grooming and training facilities- places pets already visit regularly- so owners get earlier, actionable hea...
Quick Takeaways: Why It Matters? The FDA’s Emergency Use Authorization for Simparica Trio to treat New World screwworm (NWS) larvae in dogs gives veterinarians a convenient, oral option that can be used alongside existing livestock tools (e.g., Dectomax...
Quick Takeaways: Why It Matters? By putting TRUFORMA analyzers in equine clinics at no cost and offering free PPID testing cartridges to eligible Boehringer Ingelheim customers, the program makes it much easier and faster for vets to diagnose and monitor Cus...
Quick Takeaways: Why It Matters? ECO’s licence of Vaxinano’s late‑stage sheep toxoplasmosis vaccine gives it a low‑cost, de‑risked way to add a high‑value preventative product that directly tackles a major cause of abortion and lamb losses, with peak sales estimated a...
Quick Takeaways: Why It Matters? IDEXX’s Catalyst proBNP brings a well‑known heart‑disease blood test into the vet clinic with results in minutes, so vets can spot hidden heart problems, decide quickly in breathing emergencies, and monitor patients without waiting day...
Quick Takeaways: Why It Matters? Boehringer Ingelheim’s purchase of Evax gives it a promising new way to treat common horse allergies with longer‑lasting vaccines instead of short‑term symptom relief, which could mean fewer vet visits and better outcomes for owners. If the approach works a...
Featured Article Cover Story Research Development Product Launch Clinical Trial Results The Farmer’s Dog to Acquire Woof, Expanding Into Canine Wellness and Enrichment Strategic Acquisition The Farmer’s Dog will acquire Woof, the pet wellness company behind functional enrichment products s...
